2020. Phase I Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects with Actinic Keratosis. SKIN The Journal of Cutaneous Medicine. 4, 6 (Oct. 2020), s119. DOI:https://doi.org/10.25251/skin.4.supp.119.